Psychotic Disorders - Argentina

  • Argentina
  • Revenue in the Psychotic Disorders market is projected to reach US$62.07m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of -1.16%, resulting in a market volume of US$59.23m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$2,257.00m in 2024).
  • In relation to total population figures, per person revenues of US$92.95 are generated in 2024.

Key regions: Germany, France, United States, Australia, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Psychotic Disorders market in Argentina is experiencing steady growth due to several factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the development of this market.

Customer preferences:
In Argentina, there is a growing awareness and acceptance of mental health issues, including psychotic disorders. As a result, there is an increasing demand for effective treatment options and support services. Customers are seeking treatments that not only alleviate symptoms but also improve their overall quality of life. They are looking for personalized and holistic approaches that address their unique needs and preferences. Additionally, there is a preference for therapies that have minimal side effects and are backed by scientific evidence.

Trends in the market:
One of the key trends in the Psychotic Disorders market in Argentina is the adoption of innovative therapies. Pharmaceutical companies are investing in research and development to introduce new and improved medications that target the underlying causes of psychotic disorders. These therapies aim to provide better symptom relief and reduce the risk of relapse. Additionally, there is a growing interest in non-pharmacological interventions such as cognitive-behavioral therapy and psychosocial support programs. These approaches focus on helping individuals manage their symptoms and improve their overall well-being.

Local special circumstances:
Argentina has a well-established healthcare system that provides access to mental health services. There are specialized clinics and hospitals that cater specifically to individuals with psychotic disorders. Moreover, the government has implemented policies and programs to promote mental health and improve access to treatment. This includes the provision of subsidies for medications and therapies, as well as the integration of mental health services into primary care settings. These initiatives contribute to the growth of the Psychotic Disorders market in Argentina by increasing awareness, reducing stigma, and improving access to care.

Underlying macroeconomic factors:
The economic stability and growth of Argentina play a significant role in the development of the Psychotic Disorders market. A stable economy provides individuals with the means to seek and afford treatment. Additionally, a growing middle class and increased disposable income contribute to the demand for healthcare services, including mental health treatments. Furthermore, the government's commitment to investing in healthcare infrastructure and improving access to quality care creates a conducive environment for the growth of the Psychotic Disorders market.In conclusion, the Psychotic Disorders market in Argentina is developing due to customer preferences for personalized and holistic treatments, the adoption of innovative therapies, local special circumstances such as a well-established healthcare system and government initiatives, and underlying macroeconomic factors such as economic stability and government investments in healthcare. These factors collectively contribute to the steady growth of the market and the improved availability of treatment options for individuals with psychotic disorders in Argentina.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)